bt365官网亚洲版

2016年代表论文

1.     Ablat N, Lv DY, Ren RT, Xiaokaiti Y, Ma X, Zhao X, Sun Y, et al. Neuroprotective Effects of a Standardized Flavonoid Extract from Safflower against a Rotenone-Induced Rat Model of Parkinson's Disease. Molecules 2016;21.

2.     Guan LZ, Song Y, Gao J, Gao JJ, Wang KW. Inhibition of calcium-activated chloride channel ANO1 suppresses proliferation and induces apoptosis of epithelium originated cancer cells. Oncotarget 2016;7:78619-78630.

3.     Li W, Jiang HJ, Ablat N, Wang C, Guo YF, Sun Y, Zhao X, et al. Evaluation of the acute and sub-chronic oral toxicity of the herbal formula Xiaoer Chaigui Tuire Oral Liquid. Journal of Ethnopharmacology 2016;189:290-299.

4.     Ren RT, Shi CY, Cao J, Sun Y, Zhao X, Guo YF, Wang C, et al. Neuroprotective Effects of A Standardized Flavonoid Extract of Safflower Against Neurotoxin-Induced Cellular and Animal Models of Parkinson's Disease. Scientific Reports 2016;6.

5.     Shui MY, Liu XY, Zhu YJ, Wang YY. Exogenous hydrogen sulfide attenuates cerebral ischemia-reperfusion injury by inhibiting autophagy in mice. Canadian Journal of Physiology and Pharmacology 2016;94:1187-1192.

6.     Wan D, Wang D, Sun Q, Song Y, Jiang YM, Li RT, Ye J. Antinociception of spirocyclopiperazinium salt compound LXM-10-M targeting alpha 7 nicotinic receptor and M4 muscarinic receptor and inhibiting CaMKII alpha/CREB/CGRP signaling pathway in mice. European Journal of Pharmacology 2016;770:92-98.

7.     Wei NN, Lv HN, Wu Y, Yang SL, Sun XY, Lai R, Jiang Y, et al. Selective Activation of Nociceptor TRPV1 Channel and Reversal of Inflammatory Pain in Mice by a Novel Coumarin Derivative Muralatin L from Murraya alata. Journal of Biological Chemistry 2016;291:640-651.

8.     Xiao SL, Wang Q, Si LL, Zhou XS, Zhang YM, Zhang LH, Zhou DM. Synthesis and biological evaluation of novel pentacyclic triterpene alpha-cyclodextrin conjugates as HCV entry inhibitors. European Journal of Medicinal Chemistry 2016;124:1-9.

9.     Zhu YJ, Li RY, Lin Y, Shui MY, Liu XY, Chen H, Wang YY. Engineering Factor Xa Inhibitor with Multiple Platelet-Binding Sites Facilitates its Platelet Targeting. Scientific Reports 2016;6.